 |
 Video: What is a Stock Split?
|
|
|
| Glaukos is an ophthalmic medical technology and pharmaceutical company focused on developing therapies for the treatment of glaucoma, corneal disorders, and retinal disease. Co. has developed Micro-Invasive Glaucoma Surgery as an alternative to the glaucoma treatment paradigm, a bio-activated pharmaceutical therapy for the treatment of a corneal disorder, keratoconus, as well as a pipeline of sustained pharmaceutical therapies, surgical devices, and implantable biosensors to treat glaucoma progression, corneal disorders such as keratoconus, dry eye and refractive vision correction, and retinal diseases such as neovascular age-related macular degeneration and retinal vein occlusion. According to our Glaukos stock split history records, Glaukos has had 0 splits. | |
|
Glaukos (GKOS) has 0 splits in our Glaukos stock split history database.
Looking at the Glaukos stock split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Glaukos shares, starting with a $10,000 purchase of GKOS, presented on a split-history-adjusted basis factoring in the complete Glaukos stock split history.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
06/26/2015 |
|
| End date: |
04/26/2024 |
|
| Start price/share: |
$28.00 |
|
| End price/share: |
$99.48 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
255.29% |
|
| Average Annual Total Return: |
15.42% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$35,533.08 |
|
| Years: |
8.84 |
|
|
|
|
|
